Fudan University

Fudan University logo
🇨🇳China
Ownership
Private
Established
1905-01-01
Employees
1K
Market Cap
-
Website
http://www.fudan.edu.cn

Docetaxel and Cisplatin Chemotherapy With or Without High Dose Proton Pump Inhibitor in Metastatic Breast Cancer

First Posted Date
2010-02-17
Last Posted Date
2015-03-06
Lead Sponsor
Fudan University
Target Recruit Count
94
Registration Number
NCT01069081
Locations
🇨🇳

Fudan University Cancer Hospital, Shanghai, Shanghai, China

A Trial of High Intensity Versus Low Intensity Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

First Posted Date
2010-02-09
Last Posted Date
2012-03-14
Lead Sponsor
Fudan University
Target Recruit Count
240
Registration Number
NCT01064999
Locations
🇨🇳

Cancer Hospital, Fudan University, Shanghai, Shanghai, China

Esophagectomy: Sweet Versus Ivor-Lewis (ESVIL) (ECTOP-2001)

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2010-01-12
Last Posted Date
2023-07-20
Lead Sponsor
Fudan University
Target Recruit Count
300
Registration Number
NCT01047111
Locations
🇨🇳

Fudan University Cancer Center, Shanghai, Shanghai, China

Efficacy of Postoperative Adjuvant Treatments for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis

Not Applicable
Conditions
Interventions
First Posted Date
2009-12-16
Last Posted Date
2009-12-16
Lead Sponsor
Fudan University
Target Recruit Count
260
Registration Number
NCT01033578
Locations
🇨🇳

Liver Cancer Insitute, Zhongshan Hospital, Shanghai, China

A Randomized Trial Comparing EC-wPversus EP-wP as Adjuvant Therapy for Operable Breast Cancer Patients Less Than 40 Years Old

First Posted Date
2009-12-04
Last Posted Date
2020-05-12
Lead Sponsor
Fudan University
Target Recruit Count
521
Registration Number
NCT01026116
Locations
🇨🇳

Department of Breast Surgery, Cancer Hospital, Fudan University, Shanghai, China

Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver Cancer

Phase 1
Conditions
First Posted Date
2009-10-22
Last Posted Date
2009-10-22
Lead Sponsor
Fudan University
Target Recruit Count
30
Registration Number
NCT00999843
Locations
🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Randomized Controlled Trials on Adjuvant Intraperitoneal Chemotherapy for Resectable Local Advanced Gastric Cancer

First Posted Date
2009-10-09
Last Posted Date
2010-09-08
Lead Sponsor
Fudan University
Target Recruit Count
79
Registration Number
NCT00992199
Locations
🇨🇳

Fudan University Cancer Hospital, Shanghai, Shanghai, China

Endostar Combined With CHOP Regimen as First Line Chemotherapy for Peripheral T Cell Lymphoma

Phase 2
Conditions
Interventions
First Posted Date
2009-09-10
Last Posted Date
2010-09-15
Lead Sponsor
Fudan University
Target Recruit Count
15
Registration Number
NCT00974324
Locations
🇨🇳

Fudan University Cancer Hospital, Shanghai, Shanghai, China

Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer

Phase 2
Completed
Conditions
Interventions
First Posted Date
2009-09-02
Last Posted Date
2011-07-12
Lead Sponsor
Fudan University
Target Recruit Count
141
Registration Number
NCT00970138
Locations
🇨🇳

Fudan University Cancer Hospital, ShangHai, Shanghai, China

Dexrazoxane as a Protective Agent in Anthracycline Treated Breast Cancer

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2009-08-10
Last Posted Date
2012-02-28
Lead Sponsor
Fudan University
Target Recruit Count
12
Registration Number
NCT00955890
Locations
🇨🇳

Fudan University Cancer Hospital, Shanghai, Shanghai, China

© Copyright 2024. All Rights Reserved by MedPath